Identification of tRNA-derived Fragments and Their Potential Roles in Atherosclerosis

Abstract

Objective

Atherosclerosis (AS), a chronic inflammatory disease, is the basis of cardiovascular disease (CVD). Although the treatment has been greatly improved, AS still imposes a large burden on human health and the medical system, and we still need to further study its pathogenesis. As a novel biomolecule, transfer RNA-derived fragments (tRFs) play a key role in the progression of various disease. However, whether tRFs contribute to atherosclerosis pathogenesis remains unexplored.

Methods

With deep sequencing technology, the change of tRFs expression profiles in patients with AS compared to healthy control group was identified. The accuracy of the sequencing data was validated using RT qPCR. Subsequently, we predicted the potential target genes of tRFs by online miRNA target prediction algorithms. The potential functions of tRFs were evaluated with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.

Results

There were 13 tRFs differentially expressed between patients with AS and healthy controls, of which 2 were up-regulated and 11 were down-regulated. Validation by RT-qPCR analysis confirmed the sequencing results, and tRF-Gly-GCC-009 was highly up-regulated in the AS group based on the results of sequencing which was confirmed by RT-qPCR analysis. Furthermore, GO enrichment and KEGG pathway analyses indicated that 10 signaling pathways were related to tRF-Gly-GCC-009. These pathways might be physiopathological fundamentals of AS, mainly involving in Apelin signaling, Notch signaling and calcium signaling.

Conclusion

The results of our study provide important novel insight into the underlying pathogenesis and demonstrate that tRFs might be potential biomarkers and therapeutic targets for AS in the future.

Keywords

atherosclerosis / noncoding RNAs / transfer RNA-derived fragments / bioinformatic prediction

References

[1] WeberC, NoelsH. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med, 2011, 17(11): 1410-1422

[2] HosenMR, GoodyPR, ZietzerA, et al.. MicroRNAs As Master Regulators of Atherosclerosis: From Pathogenesis to Novel Therapeutic Options. Antioxid Redox Signal, 2020, 33(9): 621-644

[3] LibbyP, RidkerPM, MaseriA. Inflammation and atherosclerosis. Circulation, 2002, 105(9): 1135-1143

[4] LibbyP, RidkerPM, HanssonGK. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, 473(7347): 317-325

[5] BlankenbergS, RupprechtHJ, BickelC, et al.. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation, 2001, 104(12): 1336-1342

[6] HahnC, SchwartzMA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol, 2009, 10(1): 53-62

[7] RosensonRS. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis, 2004, 173(1): 1-12

[8] KirchnerS, IgnatovaZ. Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat Rev Genet, 2015, 16(2): 98-112

[9] KumarP, KuscuC, DuttaA. Biogenesis and Function of Transfer RNA-Related Fragments (tRFs). Trends Biochem Sci, 2016, 41(8): 679-689

[10] MartinezG, ChoudurySG, SlotkinRK. tRNA-derived small RNAs target transposable element transcripts. Nucleic Acids Res, 2017, 45(9): 5142-5152

[11] LeeYS, ShibataY, MalhotraA, et al.. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev, 2009, 23(22): 2639-2649

[12] ZhuL, LiuX, PuW, et al.. tRNA-derived small non-coding RNAs in human disease. Cancer Lett, 2018, 419: 1-7

[13] ShenL, HongX, ZhouW, et al.. Expression profiles of tRNA-derived fragments and their potential roles in ovarian endometriosis. Epigenomics, 2020, 12(3): 183-197

[14] SingletonCK, DeludeRL, KenR, et al.. Structure, expression, and regulation of members of the developmentally controlled V and H gene classes from Dictyostelium. Dev Genet, 1991, 12(1–2): 88-97

[15] ShenY, YuX, ZhuL, et al.. Transfer RNA-derived fragments and tRNA halves: biogenesis, biological functions and their roles in diseases. J Mol Med (Berl), 2018, 96(11): 1167-1176

[16] KumarP, MudunuriSB, AnayaJ, et al.. tRFdb: a database for transfer RNA fragments. Nucleic Acids Res, 2015, 43: D141-145 Database issue)

[17] BabskiJ, MaierLK, HeyerR, et al.. Small regulatory RNAs in Archaea. RNA Biol, 2014, 11(5): 484-493

[18] MauteRL, SchneiderC, SumazinP, et al.. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proc Natl Acad Sci USA, 2013, 110(4): 1404-1409

[19] ChenH, XuZ, LiuD. Small non-coding RNA and colorectal cancer. J Cell Mol Med, 2019, 23(5): 3050-3057

[20] GuzziN, CieslaM, NgocPCT, et al.. Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells. Cell, 2018, 173(5): 1204-1216 e26

[21] LiP, TangT, LiuT, et al.. Systematic Analysis of tRNA-Derived Small RNAs Reveals Novel Potential Therapeutic Targets of Traditional Chinese Medicine (Buyang-Huanwu-Decoction) on Intracerebral Hemorrhage. Int J Biol Sci, 2019, 15(4): 895-908

[22] American College of Cardiology Foundation/American Heart Association Task FAmerican Stroke AAmerican Association of Neuroscience N. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. J Neurointerv Surg, 2011, 3(2): 100-130

[23] FoxK, GarciaMA, ArdissinoD, et al.. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J, 2006, 27(11): 1341-1381

[24] Cholesterol Treatment Trialists CMihaylovaB, EmbersonJ, et al.. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet, 2012, 380(9841): 581-590

[25] OberbauerV, SchaeferMR. tRNA-Derived Small RNAs: Biogenesis, Modification, Function and Potential Impact on Human Disease Development. Genes (Basel), 2018, 9(12): 607

[26] OlvedyM, ScaravilliM, HoogstrateY, et al.. A comprehensive repertoire of tRNA-derived fragments in prostate cancer. Oncotarget, 2016, 7(17): 24 766-24 777

[27] ZhouK, DiebelKW, HolyJ, et al.. A tRNA fragment, tRF5-Glu, regulates BCAR3 expression and proliferation in ovarian cancer cells. Oncotarget, 2017, 8(56): 95 377-95 391

[28] ElkordyA, MishimaE, NiizumaK, et al.. Stress-induced tRNA cleavage and tiRNA generation in rat neuronal PC12 cells. J Neurochem, 2018, 146(5): 560-569

[29] ZhangY, CaiF, LiuJ, et al.. Transfer RNA-derived fragments as potential exosome tRNA-derived fragment biomarkers for osteoporosis. Int J Rheum Dis, 2018, 21(9): 1659-1669

[30] YinM, LiC, JiangJ, et al.. Cell adhesion molecule-mediated therapeutic strategies in atherosclerosis: From a biological basis and molecular mechanism to drug delivery nanosystems. Biochem Pharmacol, 2021, 186: 114 471

[31] ChengJ, LuoX, HuangZ, et al.. Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases. J Cell Physiol, 2019, 234(8): 12 149-12 160

[32] SiebelC, LendahlU. Notch Signaling in Development, Tissue Homeostasis, and Disease. Physiol Rev, 2017, 97(4): 1235-1294

[33] PannellaM, CalicetiC, FortiniF, et al.. Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells. J Cell Physiol, 2016, 231(12): 2700-1710